Masimo SedLine PSi has potential to improve brain monitoring for DISE patients

Masimo announced the findings of a study published in Frontiers in Neuroscience in which Dr. Lichy Han and colleagues at Stanford University evaluated the ability of Masimo SedLine brain function monitoring to assess the sedation levels of patients undergoing drug-induced sleep endoscopy, DISE, with dexmedetomidine – a sedative with numerous advantages. The researchers found that Masimo Patient State Index PSI , a SedLine parameter derived from electroencephalographic EEG data, was statistically significantly associated with dexmedetomidine dosage, and, along with another EEG metric, “better captured changes in brain state from dexmedetomidine and ha(s) potential to improve the monitoring of dexmedetomidine sedation.”1